1-3 of 3
Stéphanie Dulucq
Close
Sort by
Journal Articles

Achieving a Complete Molecular Remission Under Imatinib Therapy Is Associated with a Better Outcome in Chronic Phase Chronic Myeloid Leukaemia Patients On Imatinib Frontline Therapy

Gabriel Etienne, MD, PHD, Nicolini E Nicolini, MD, PhD, Stéphanie Dulucq, Anna Schmitt, Sandrine Hayette, Éric Lippert, MD, PhD, Isabelle Tigaud, MD, Stephane Morisset, Stat., Caroline Bureau, Didier Adiko, Gerald Marit, MD, Josy Reiffers, MD, Francois-Xavier Mahon, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 3754.
https://doi.org/10.1182/blood.V120.21.3754.3754
Published: 2012
Journal Articles

A More Sensitive RQ-PCR to Assess Complete Molecular Remission Does Not Allow the Prediction of Relapse After Discontinuation of Imatinib In Chronic Myeloid Leukemia.

Francois-Xavier Mahon, MD, PhD, Stéphanie Dulucq, Francois Guilhot, Laurence Legros, MD, Philippe Rousselot, MD, PhD, Coralie Belanger, Gabriel Etienne, Josy Reiffers, Delphine Rea, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 2298.
https://doi.org/10.1182/blood.V116.21.2298.2298
Published: 2010
Journal Articles

Paroxysmal Nocturnal Hemoglobinuria and Pregnancy: The French Experience.

Sophie de Guibert, Régis Peffault de Latour, Nathalie Varoqueaux, Hélène Labussiere, Bernard Rio, Dominique Jaulmes, Jean-Richard Eveillard, Stéphanie Dulucq, Anne Marie Stoppa, Didier Bouscary, François Girodon, Bernard Bonnotte, Gérard Socié, Thierry Lamy
Journal: Blood
Blood (2009) 114 (22): 1984.
https://doi.org/10.1182/blood.V114.22.1984.1984
Published: 2009